AngioDynamics (ANGO) Competitors $11.04 -0.01 (-0.08%) As of 09:37 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANGO vs. TMO, WST, IART, OFIX, SRDX, ARAY, RMTI, ABT, ISRG, and BSXShould you be buying AngioDynamics stock or one of its competitors? The main competitors of AngioDynamics include Thermo Fisher Scientific (TMO), West Pharmaceutical Services (WST), Integra LifeSciences (IART), Orthofix Medical (OFIX), Surmodics (SRDX), Accuray (ARAY), Rockwell Medical (RMTI), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), and Boston Scientific (BSX). These companies are all part of the "medical" sector. AngioDynamics vs. Its Competitors Thermo Fisher Scientific West Pharmaceutical Services Integra LifeSciences Orthofix Medical Surmodics Accuray Rockwell Medical Abbott Laboratories Intuitive Surgical Boston Scientific Thermo Fisher Scientific (NYSE:TMO) and AngioDynamics (NASDAQ:ANGO) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk. Do institutionals & insiders have more ownership in TMO or ANGO? 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Comparatively, 6.0% of AngioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is TMO or ANGO more profitable? Thermo Fisher Scientific has a net margin of 15.24% compared to AngioDynamics' net margin of -10.67%. Thermo Fisher Scientific's return on equity of 16.82% beat AngioDynamics' return on equity.Company Net Margins Return on Equity Return on Assets Thermo Fisher Scientific15.24% 16.82% 8.38% AngioDynamics -10.67%-3.16%-2.07% Does the media favor TMO or ANGO? In the previous week, Thermo Fisher Scientific had 41 more articles in the media than AngioDynamics. MarketBeat recorded 63 mentions for Thermo Fisher Scientific and 22 mentions for AngioDynamics. Thermo Fisher Scientific's average media sentiment score of 1.29 beat AngioDynamics' score of 0.71 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 50 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive AngioDynamics 7 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, TMO or ANGO? Thermo Fisher Scientific has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, AngioDynamics has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Do analysts recommend TMO or ANGO? Thermo Fisher Scientific currently has a consensus price target of $590.60, suggesting a potential upside of 10.14%. AngioDynamics has a consensus price target of $19.33, suggesting a potential upside of 73.86%. Given AngioDynamics' higher probable upside, analysts clearly believe AngioDynamics is more favorable than Thermo Fisher Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Thermo Fisher Scientific 0 Sell rating(s) 6 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.71AngioDynamics 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has preferable earnings and valuation, TMO or ANGO? Thermo Fisher Scientific has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThermo Fisher Scientific$43.21B4.69$6.34B$17.2931.01AngioDynamics$300.72M1.52-$33.99M-$0.78-14.26 SummaryThermo Fisher Scientific beats AngioDynamics on 12 of the 16 factors compared between the two stocks. Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANGO vs. The Competition Export to ExcelMetricAngioDynamicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$455.26M$6.99B$6.09B$10.54BDividend YieldN/A1.16%5.69%4.71%P/E Ratio-14.2627.6685.6527.61Price / Sales1.52195.34538.60201.06Price / Cash22.6921.7337.9261.55Price / Book2.565.4512.966.76Net Income-$33.99M$178.04M$3.30B$275.88M7 Day Performance-5.28%4.21%4.32%2.81%1 Month Performance1.00%12.27%9.47%9.24%1 Year Performance82.89%34.25%84.27%35.42% AngioDynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANGOAngioDynamics4.0535 of 5 stars$11.12+0.6%$19.33+73.9%+89.1%$455.26M$300.72M-14.26760Earnings ReportAnalyst ForecastAnalyst RevisionTMOThermo Fisher Scientific4.8905 of 5 stars$461.95-0.5%$588.35+27.4%-9.9%$175.30B$43.21B26.72125,000Positive NewsAnalyst ForecastWSTWest Pharmaceutical Services4.863 of 5 stars$260.04-0.6%$318.56+22.5%-6.5%$18.81B$2.89B38.9310,600Analyst ForecastIARTIntegra LifeSciences3.6293 of 5 stars$13.63+3.3%$18.43+35.2%-15.3%$1.03B$1.61B-2.094,396News CoverageAnalyst ForecastOFIXOrthofix Medical3.0411 of 5 stars$14.36+0.5%$21.75+51.5%-4.8%$564.37M$799.49M-4.531,616Positive NewsAnalyst ForecastSRDXSurmodics4.5332 of 5 stars$29.91-0.1%$43.00+43.8%-24.8%$428.07M$126.08M-24.32450News CoverageAnalyst ForecastARAYAccuray4.455 of 5 stars$1.63-2.4%$5.00+206.7%-8.7%$188.17M$458.51M-81.501,040News CoverageAnalyst ForecastGap UpRMTIRockwell Medical3.1739 of 5 stars$1.27flat$4.00+215.0%-64.4%$43.73M$87.97M-21.17300Positive NewsAnalyst ForecastShort Interest ↑ABTAbbott Laboratories4.9594 of 5 stars$133.01-0.4%$145.22+9.2%+17.3%$232.44B$43.11B16.67114,000Trending NewsUpcoming EarningsAnalyst ForecastISRGIntuitive Surgical4.9536 of 5 stars$439.22-0.4%$595.95+35.7%-6.8%$158.13B$8.35B61.2615,638Trending NewsAnalyst ForecastBSXBoston Scientific4.9289 of 5 stars$96.89-1.3%$118.38+22.2%+12.7%$145.48B$16.75B57.6753,000Analyst Forecast Related Companies and Tools Related Companies Thermo Fisher Scientific Competitors West Pharmaceutical Services Competitors Integra LifeSciences Competitors Orthofix Medical Competitors Surmodics Competitors Accuray Competitors Rockwell Medical Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Boston Scientific Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANGO) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
